Elizabeth R

Jun 15, 2024 | academic.oup.com | Columbus OH |Elizabeth R |Elaine R. Mardis

Identifying germline predisposition in CNS malignancies is of increasing clinical importance, as it contributes to diagnosis and prognosis, and determines aspects of treatment. Inclusion of germline testing has historically been limited due to challenges surrounding access to genetic counseling, complexity in acquiring a germline comparator specimen, concerns about the impact of findings, or cost considerations.